GSK (GSK) P/B (1999 - 2026)
GSK (GSK) P/B from Nov 1, 1999 to Jul 21, 2026. The TTM GSK (GSK) P/B is 3.32. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of GSK (GSK)
| Year | P/B | Change |
|---|---|---|
| 2026 | 3.32 | +46.12% |
| 2025 | 2.27 | -44.50% |
| 2024 | 4.10 | +4.21% |
| 2023 | 3.93 | -37.57% |
| 2022 | 6.30 | +54.60% |
| 2021 | 4.07 | +19.73% |
| 2020 | 3.40 | -42.21% |
| 2019 | 5.89 | -65.57% |
| 2018 | 17.11 | -66.42% |
| 2017 | 50.94 | -90.34% |
| 2016 | 527.09 | +3968.98% |
| 2015 | 12.95 | -17.19% |
| 2014 | 15.64 | +39.09% |
| 2013 | 11.25 | -0.59% |
| 2012 | 11.31 | +13.69% |
| 2011 | 9.95 | +38.40% |
| 2010 | 7.19 | +8.54% |
| 2009 | 6.62 | -19.30% |
| 2008 | 8.21 | +11.99% |
| 2007 | 7.33 | +52.91% |
| 2006 | 4.79 | +16.08% |
| 2005 | 4.13 | +6.52% |
| 2004 | 3.88 | +1.65% |
| 2003 | 3.81 | +24.45% |
| 2002 | 3.06 | -24.81% |
| 2001 | 4.08 | -11.04% |
| 2000 | 4.58 | +0.21% |
| 1999 | 4.57 | N/A |
Comparison GSK (GSK) P/B with competitors
GSK (GSK) P/B is 3.32.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -79.42% |
| GRFS | Grifols SA | 0.79 | -76.23% |
| SNY | Sanofi | 1.27 | -61.78% |
| BIIB | Biogen Inc | 1.52 | -54.29% |
| PFE | Pfizer Inc | 1.55 | -53.42% |
| OGN | Organon & Company | 3.93 | +18.14% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | +23.11% |
| BMY | Bristol-Myers Squibb Company | 6.04 | +81.75% |
| AZN | Astrazeneca plc | 6.20 | +86.57% |
| MRK | Merck & Co Inc | 6.68 | +101.01% |
| GILD | Gilead Sciences Inc | 6.94 | +108.84% |
| NVO | Novo Nordisk | 7.07 | +112.75% |
| NVS | Novartis AG | 7.60 | +128.70% |
| JNJ | Johnson & Johnson | 7.64 | +129.90% |
| NSRX | Nasus Pharma Ltd | 12.90 | +288.18% |
| MDCX | MDCorp | 15.34 | +361.61% |
| AMGN | AMGEN Inc | 21.17 | +537.04% |
| SCLX | Scilex Holding Company | 28.85 | +768.14% |
| LLY | Lilly(Eli) & Company | 32.94 | +891.22% |
| ABBV | Abbvie Inc | 50.46 | +1418.43% |